Morgan Stanley
PROK icon

Morgan Stanley’s ProKidney PROK Stock Holding History

Morgan Stanley’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Buy
8,955,967
+138,966
+2% +$295K ﹤0.01% 3163
2025
Q4 		$19.8M Buy
8,817,001
+2,069,979
+31% +$5.44M ﹤0.01% 2945
2025
Q3 		$16.3M Buy
6,747,022
+759,481
+13% +$2.02M ﹤0.01% 3075
2025
Q2 		$3.55M Sell
5,987,541
-4,349,682
-42% -$3.39M ﹤0.01% 4338
2025
Q1 		$9.06M Sell
10,337,223
-3,636,134
-26% -$5.05M ﹤0.01% 3430
2024
Q4 		$23.6M Sell
13,973,357
-297,028
-2% -$535K ﹤0.01% 2595
2024
Q3 		$27.4M Sell
14,270,385
-177,956
-1% -$404K ﹤0.01% 2473
2024
Q2 		$35.5M Buy
14,448,341
+4,121,663
+40% +$11.1M ﹤0.01% 2072
2024
Q1 		$16.9M Sell
10,326,678
-12,067,720
-54% -$17.7M ﹤0.01% 2873
2023
Q4 		$39.9M Buy
22,394,398
+12,108,032
+118% +$26M ﹤0.01% 2692
2023
Q3 		$47.1M Buy
10,286,366
+590,964
+6% +$5.66M ﹤0.01% 1637
2023
Q2 		$108M Buy
9,695,402
+84,317
+0.9% +$897K 0.01% 1038
2023
Q1 		$109M Sell
9,611,085
-1,336,410
-12% -$14.2M 0.01% 1010
2022
Q4 		$75.1M Buy
10,947,495
+595,839
+6% +$5.69M 0.01% 1210
2022
Q3 		$93.3M Buy
+10,351,656
New +$90.1M 0.01% 930
2022
Q1 		– Sell
-9,456
Closed -$94K – 8081
2021
Q4 		$94K Buy
9,456
+2,600
+38% +$25.7K ﹤0.01% 6484
2021
Q3 		$67K Buy
+6,856
New +$67.5K ﹤0.01% 6584

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley's PROK Position: Q1 2026 in Review

Morgan Stanley increased its ProKidney (PROK) stake by 1.6% in Q1 2026, buying an estimated $295K and bringing the position to 8,955,967 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

Morgan Stanley first reported a position in PROK in Q3 2021 and has held it in 17 quarters since. The position peaked at $109M in Q1 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Morgan Stanley held 8,955,967 shares of ProKidney worth $16M as of Q1 2026.
  • Morgan Stanley bought 138,966 ProKidney shares in Q1 2026, an estimated $295K.
  • ProKidney made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3163 holding.
  • Morgan Stanley first reported a position in ProKidney in Q3 2021 and has held it in 17 quarters since.
  • Morgan Stanley's ProKidney position peaked at $109M in Q1 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.